Publications

5600 Results

Breast cancer outlook for 2017: keeping the accelerator to the floor

Authors
V Gadi;J Gralow
Journal / Conference
Oncology (Williston Park)
Year
2016
Research Committee(s)
Breast
PMID
PMID27933601
Study Number(s)
S1416

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

Authors
M Golshan;C Cirrincione;W Sikov;LA Carey;DA Berry;BA Overmoyer;NL Henry;G Somlo;E Port;H Burstein;C Hudis;E Winer;D Ollila
Journal / Conference
Breast Cancer Research and Treatment
Year
2016
Research Committee(s)
Breast
PMID
PMID27704226
PMC
PMC5189982

Relationship between metformin use and recurrence and survival in patients with resected stage III colon cancer receiving adjuvant chemotherapy: results from North Central Cancer Treatment Group N0147 (Alliance)

Authors
P Singh;Q Shi;N Foster;A Grothey;S Nair;E Chane;A Shields;R Goldberg;S Gill;M Kahlenberg;F Sinicrope;D Sargent;S Alberts
Journal / Conference
Oncologist Dec;21(12):1509-1521; Epub 2016 Nov 23
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID27881709
PMC
PMC5153338
Study Number(s)
CTSU/N0147

Adverse health effects of intermittent vs continuous androgen deprivation therapy for metastatic prostate cancer - Reply

Authors
D Hershman;J Unger
Journal / Conference
JAMA Oncology May 1;2(5):686-687
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID27244679
Study Number(s)
SWOG-9346

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Authors
Gu Z;M Churchman;K Roberts;Y Li;R Harvey;K McCastlain;S Reshmi;D Payne-Turner;I Iacobucci;Y Shao;IM Chen;M Valentine;D Pei;K Mungall;A Mungall;Y Ma;R Moore;M Marra;E Stonerock;J Gastier-Foster;M Devidas;Y Dai;B Wood;M Borowitz;E Larsen;K Maloney;L Mattano;A Angiolillo;W Salzer;M Burke;F Gianni;O Spinnelli;JP Radich;MD Minden;A Moorman;B Patel;A Fielding;J Rowe;S Luger;R Bhatia;I Aldoss;SJ Forman;J Kohlschmidt;K Mrozek;G Marcucci;C Bloomfield;W Stock;W Kornblau;H Kantarjian;M Konopleva;E Paietta;C Willman;M Loh;S Hunger;C Mullighan
Journal / Conference
Nature Communications Nov 8;7:13331
Year
2016
Research Committee(s)
Leukemia
PMID
PMID27824051
PMC
PMC5105166
Study Number(s)
S0333, SWOG-9400, S9910

S0502: A SWOG phase III randomized study of imatinib, with or without bevacizumab, in patients with untreated metastatic or unresectable gastrointestinal stromal tumors

Authors
CD Blanke;C Rankin;C Corless;J Eary;P Okuno;S George;M Heinrich
Journal / Conference
The Oncologist Dec;20(12):1353-1354
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID26576593
PMC
PMC4679092
Study Number(s)
S0502

SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early breast cancer

Authors
GT Budd;W Barlow;HCF Moore;T Hobday;JA Stewart;C Isaacs;M Salim;J Cho;K Rinn;K Albain;H Chew;GV Burton;TD Moore;G Srkalovic;BA McGregor;LE Flaherty;RB Livingston;DL Lew;JR Gralow;GN Hortobagyi
Journal / Conference
Journal of Clinical Oncology 33(1):58-64
Year
2015
Research Committee(s)
Breast
PMID
PMID25422488
PMC
PMC4268253
Study Number(s)
S0221

Pharmacogenetic analysis of INT 0144 trial: association of polymorphisms with survival and toxicity in rectal cancer patients treated with 5-FU and radiation

Authors
P Bohanes;C Rankin;H Lenz;T Winder;C Ulrich;S Smalley;K Danenberg;K Makar;W Zhang;J Benedetti;C Blanke
Journal / Conference
Clinical Cancer Research Apr 1;21(7):1583-1590
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID25589620
PMC
PMC4566931
Study Number(s)
SWOG-9304 (INT-0144)

A phase III study of radiation therapy (RT) and O6-benzylguanine, (O6BG) plus BCNU versus RT and BCNU alone and methylation status in newly diagnosed GBM and gliosarcoma: SWOG study S0001

Authors
D Blumenthal;C Rankin;K Stelzer;A Spence;A Sloan;D Moore;K Yost;S Schulman;E Rushing
Journal / Conference
International Journal of Clinical Oncology Aug;20(4):650-658
Year
2015
Research Committee(s)
Brain
PMID
PMID25407559
PMC
PMC4465052
Study Number(s)
S0001

Ibritumomab Consolidation After 3 Cycles of CHOP Plus Radiotherapy in High-Risk Limited-Stage Aggressive B-cell Lymphoma: SWOG S0313

Authors
D Persky;TP Miller;J Unger;BD Stea;OW Press;LS Constine;K Barton;JW Friedberg;M Leblanc;RI Fisher
Journal / Conference
Blood Jan 8;125(2):236-241
Year
2015
Research Committee(s)
Lymphoma
PMID
PMID25395425
PMC
PMC4287635
Study Number(s)
S0313